Lexaria Bioscience CORP. (LEXX) — SC 13D/A Filings

All SC 13D/A filings from Lexaria Bioscience CORP.. Browse 4 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (4)

Boos Amends Lexaria Bioscience Stake Filing — Sep 23, 2024 Risk: medium
Wayne W. Boos has amended their Schedule 13D filing for Lexaria Bioscience Corp. as of August 31, 2024. The filing indicates a change in beneficial ownership, t
Lexaria Bioscience Corp. 13D/A Filing - Ownership Update — Aug 6, 2024 Risk: medium
On August 6, 2024, Lexaria Bioscience Corp. filed an amendment (No. 3) to its Schedule 13D. This filing relates to the acquisition of common stock by Boos Wayne
Lexaria Bioscience Corp. 13D/A Filing — Apr 25, 2024 Risk: medium
On April 25, 2024, Lexaria Bioscience Corp. filed an amendment (No. 2) to its Schedule 13D. This filing relates to the acquisition of common stock by Boos Wayne
Boos Amends Lexaria Bioscience Ownership Filing — Feb 14, 2024 Risk: medium
Wayne W. Boos filed an Amendment No. 1 to Schedule 13D (SC 13D/A) on February 14, 2024, regarding his beneficial ownership in Lexaria Bioscience Corp. common st

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX